Aspergillus spp. renal arteritis after kidney transplantation: A reappraisal.


Journal

Transplant infectious disease : an official journal of the Transplantation Society
ISSN: 1399-3062
Titre abrégé: Transpl Infect Dis
Pays: Denmark
ID NLM: 100883688

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 24 06 2021
accepted: 13 07 2021
medline: 23 10 2023
pubmed: 28 7 2023
entrez: 28 7 2023
Statut: ppublish

Résumé

Aspergillus spp. is an uncommon and life-threatening cause of transplantrenal artery pseudoaneurysm after kidney transplantation. We report the case of a 62-year-old woman who underwent kidney transplantation 10 months before and presented a 7-cm asymptomatic transplant renal artery pseudoaneurysm. Transplanted kidney and pseudoaneurysm were surgically removed in emergency. Renal graft, urine, and pseudoaneurysm cultures grew Aspergillus flavus. She recovered after 12 months of antifungal therapy. To date 14 cases of Aspergillus spp. renal arteritis after kidney transplantation have been published, including 50% Aspergillus flavus arteritis. Vast majority were diagnosed within 90 days after transplantation (73%). Despite allograft nephrectomy and antifungal therapy, mortality rate was high (33%).

Sections du résumé

BACKGROUND BACKGROUND
Aspergillus spp. is an uncommon and life-threatening cause of transplantrenal artery pseudoaneurysm after kidney transplantation.
CASE METHODS
We report the case of a 62-year-old woman who underwent kidney transplantation 10 months before and presented a 7-cm asymptomatic transplant renal artery pseudoaneurysm. Transplanted kidney and pseudoaneurysm were surgically removed in emergency. Renal graft, urine, and pseudoaneurysm cultures grew Aspergillus flavus. She recovered after 12 months of antifungal therapy.
LITERATURE REVIEW METHODS
To date 14 cases of Aspergillus spp. renal arteritis after kidney transplantation have been published, including 50% Aspergillus flavus arteritis. Vast majority were diagnosed within 90 days after transplantation (73%). Despite allograft nephrectomy and antifungal therapy, mortality rate was high (33%).

Identifiants

pubmed: 37504382
doi: 10.1111/tid.14108
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14108

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Albano L, Bretagne S, Mamzer-Bruneel MF, et al. Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis. 2009;48(2):194-202.
Chung MM, Chan YC, Law Y, Cheng SW. Infectious anastomotic pseudoaneurysm complicating renal allograft: case report and review of literature. Int J Nephrol Renovasc Dis. 2017;10:55-60.
Heylen L, Maertens J, Naesens M, et al. Invasive aspergillosis after kidney transplant: case-control study. Clin Infect Dis. 2015;60(10):1505-1511.
Desbois A-C, Poiree S, Snanoudj R, et al. Prognosis of invasive aspergillosis in kidney transplant recipients: a case-control study. Transplant Direct [Internet]. 2016;2(8). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082998/
Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70(3):270-277.
Gavaldà J, Meije Y, Fortún J, et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20(s7):27-48.
Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101-1111.
López-Medrano F, Fernández-Ruiz M, Silva JT, et al. clinical presentation and determinants of mortality of invasive pulmonary aspergillosis in kidney transplant recipients: a multinational cohort study. Am J Transplant. 2016;16(11):3220-3234.
Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW, Meis JF. Invasive aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J Fungi. 2019;5(3).
Garrido J, Labrador P, Lerma L, et al. Vascular Aspergillus infection in two recipients of kidneys from the same donor. Nefrologia. 2004;24 (Suppl 3):30-34.
Zhan H, Lv Y, Zhang Y, Liu C, Wang B. Hepatic and renal artery rupture due to aspergillus and mucor mixed infection after combined liver and kidney transplantation: a case report. Transplant Proc. 2008;40(5):1771-1773.
Wang R, Wu J, Wang Y, Huang H, He Q, Chen J. Aspergillus infection limited to the anastomosed artery following renal transplantation: a report of 4 cases. Transpl Infect Dis. 2009;11(4):363-366.
Minz m, Sharma A, Kumar S, Singh S, Shivaprakash M, Bag S. Use of autogenous internal iliac artery for bridging the external iliac artery after excision of Aspergillus mycotic aneurysm in renal transplant recipients. J Vasc Surg. 2011;53(3):802-804.
Ram Reddy C, Ram R, Swarnalatha G, et al. “True” mycotic aneurysm of the anastomotic site of the renal allograft artery. Exp Clin Transplant. 2012;10(4):398-402.
George S, Al-Waheeb S. Aspergillus fungal arteritis causing vascular anastomotic rupture and loss of commercially transplanted kidney. Indian J Pathol Microbiol. 2014;57(4):643.
Tang M, Xu X, Shen B, et al. Fifty-one cases of fungal arteritis after kidney transplantation: a case report and review of the literature. Transpl Infect Dis. 2017;19(6):e12781.
Asif S, Bennett J, Pauly RR. A rare case of an infectious pseudoaneurysm due to aspergillus flavus in the setting of renal transplant. Cureus. 2019;11(3):e4208.
Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-50.
Patterson TF, Thompson GR, Denning DW, et al. Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):433-442.
Bracale U, Santangelo M, Carbone F. Anastomotic pseudoaneurysm complicating renal transplantation: treatment options. Eur J Vasc Endovasc Surg. 2010;39(5):565-568.
Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect. 2011;17(3):409-417.

Auteurs

Romain Gueneau (R)

Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.

Chloé Giret (C)

Service de néphrologie, Hypertension, Dialyses, Transplantation, Centre, Hospitalier Régional Universitaire, Tours, France.

Emmanuel Lafont (E)

Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.

Matthieu Buchler (M)

Service de néphrologie, Hypertension, Dialyses, Transplantation, Centre, Hospitalier Régional Universitaire, Tours, France.

Hélène Longuet (H)

Service de néphrologie, Hypertension, Dialyses, Transplantation, Centre, Hospitalier Régional Universitaire, Tours, France.

Marie-Christine Machet (MC)

Service d'anatomopathologie, Centre Hospitalier Régional Universitaire, Tours, France.

Nadia Ghazzar (N)

Service de Médecine Nucléaire, Hôpital Européen Georges Pompidou, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.

Fanny Lanternier (F)

Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.
CNRS, Molecular Mycology Unit UMR 2000, Institut Pasteur, Paris, France.

Olivier Lortholary (O)

Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.
CNRS, Molecular Mycology Unit UMR 2000, Institut Pasteur, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH